SCHEMBL7597901

SCHEMBL7597901

O=C(NCC(F)(F)F)OC1(CCCCN2CCCN(c3ccc4cc(Cl)ccc4n3)CC2)c2ccccc2Oc2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 10/20 0.37
DRD2 P14416 8/20 0.37
DRD3 P35462 6/20 0.37
HTR3A P46098 1/20 0.36
HRH4 Q9H3N8 1/20 0.36
SLC6A4 P31645 4/20 0.36
DRD4 P21917 4/20 0.34
HTR2A P28223 3/20 0.34
HTR2C P28335 3/20 0.34
HTR7 P34969 3/20 0.34
TMEM97 Q5BJF2 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
HRH1 P35367 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7595172 0.97 HTR1A (0.39) HTR1ADRD2DRD3HTR3AHRH4
SCHEMBL7599590 0.92 HTR1A (0.39) HTR1ADRD2DRD3HTR3AHRH4
SCHEMBL7600196 0.92 DRD3 (0.44) HTR1ADRD2DRD3HTR3ASLC6A4
SCHEMBL7599794 0.89 DRD2 (0.43) HTR1ADRD2DRD3HTR3ADRD4
SCHEMBL7600219 0.89 HTR1A (0.41) HTR1ADRD2DRD3HTR3AHRH4
SCHEMBL6771131 0.89 DRD3 (0.39) HTR1ADRD2DRD3HTR3AHRH4
SCHEMBL7595828 0.89 DRD3 (0.38) HTR1ADRD2DRD3HTR3ADRD4
SCHEMBL7598996 0.89 HRH3 (0.39) HTR1ADRD2DRD3DRD4HTR2A
SCHEMBL7598985 0.88 HTR1A (0.41) HTR1ADRD2DRD3SLC6A4HTR2A
SCHEMBL6770160 0.86 DRD3 (0.41) HTR1ADRD2DRD3HTR3AHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255736-A2 SUBSTITUTED PIPERAZINE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) Boehringer Ingelheim Pharma KG (DE) 2002-11-13 EP disclosed
WO-2001047898-A2 SUBSTITUTED PIPERAZINE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-07-05 WO disclosed